These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Gene expression analysis in Merkel cell polyomavirus-positive non-small cell lung cancer from Japanese patients. Hashida Y; Imajoh M; Daibata M Int J Cancer; 2013 Dec; 133(12):3014-5. PubMed ID: 23740604 [No Abstract] [Full Text] [Related]
7. Molecular pathological findings of Merkel cell polyomavirus in lung cancer: a possible etiopathogenetic link? Antoniou KM; Lasithiotaki I; Symvoulakis E; Derdas SP; Psaraki A; Spandidos DA; Stathopoulos EN; Siafakas NM; Sourvinos G Int J Cancer; 2013 Dec; 133(12):3016-7. PubMed ID: 23740689 [No Abstract] [Full Text] [Related]
8. Synergistic antitumor efficacy of sequentially combined paclitaxel with sorafenib in vitro and in vivo NSCLC models harboring KRAS or BRAF mutations. Zhang XH; Shin JY; Kim JO; Oh JE; Yoon SA; Jung CK; Kang JH Cancer Lett; 2012 Sep; 322(2):213-22. PubMed ID: 22433711 [TBL] [Abstract][Full Text] [Related]
9. BRAF-mutations in non-small cell lung cancer. Brustugun OT; Khattak AM; Trømborg AK; Beigi M; Beiske K; Lund-Iversen M; Helland Å Lung Cancer; 2014 Apr; 84(1):36-8. PubMed ID: 24552757 [TBL] [Abstract][Full Text] [Related]
10. BRAF Mutations-A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC? Arulananda S; Mitchell P J Thorac Oncol; 2018 Aug; 13(8):1055-1057. PubMed ID: 30056857 [No Abstract] [Full Text] [Related]
11. A SNaPshot into a tumor's genotype: rapid, comprehensive genotyping possible in routine clinical practice. Miller S Bioanalysis; 2011 Dec; 3(24):2705. PubMed ID: 22185268 [No Abstract] [Full Text] [Related]
12. Severe acute interstitial lung disease after crizotinib therapy in a patient with EML4-ALK-positive non-small-cell lung cancer. Tamiya A; Okamoto I; Miyazaki M; Shimizu S; Kitaichi M; Nakagawa K J Clin Oncol; 2013 Jan; 31(1):e15-7. PubMed ID: 23169500 [No Abstract] [Full Text] [Related]
13. The presence of HER2 exon 20 insertion in patients with central nervous system metastases from non-small lung cancer--a potential application in classification for therapy. Nicoś M; Krawczyk P; Mlak R; Sawicki M; Jarosz B; Powrózek T; Milanowski P; Trojanowski T; Milanowski J Pneumonol Alergol Pol; 2013; 81(4):294-7. PubMed ID: 23744164 [TBL] [Abstract][Full Text] [Related]
18. Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer. Kim SJ; Kim DW; Kim TM; Lee SH; Heo DS; Bang YJ J Clin Oncol; 2012 Jun; 30(16):e147-50. PubMed ID: 22508824 [No Abstract] [Full Text] [Related]